Cerebral Malaria

Species Restriction (key)

Essentially EXCLUSIVELY P. falciparum (general malaria biology = Malaria topic). Other species don’t cause this — cerebral malaria = marker of severe falciparum infection specifically, narrows thinking even pre-speciation.

Pathogenesis — SEQUESTRATION, not neuroinvasion (key contrast vs rest of section)

NOT direct parasite invasion of neurons/CNS tissue (unlike bacteria/most CNS viruses). Mechanism: infected RBCs express PfEMP1 (parasite surface protein) → CYTOADHERENCE to vascular endothelium → sequestration in CEREBRAL MICROVASCULATURE (avoids splenic clearance). Same general cytoadherence process occurs in other vascular beds too — not brain-specific mechanism. → Microvascular obstruction + local hypoxia + inflammation = drives encephalopathy. NOT direct parasite presence in neural tissue. High-yield pathogenic distinction from rest of section.

Clinical

DEFINITION: unarousable coma + P. falciparum parasitemia, other causes excluded. DIAGNOSIS OF EXCLUSION in right epi/parasitological context — no unique confirmatory finding of its own. Seizures common, esp. children (leading cause severe illness/death, sub-Saharan Africa + India). Substantial mortality even treated. Survivors (esp. children): long-term neuro sequelae (cognitive impairment, motor deficits, epilepsy) — major burden beyond acute mortality. HYPOGLYCEMIA: important co-occurring complication — parasite glucose consumption + impaired hepatic gluconeogenesis + quinine’s insulin-secretagogue effect (if used). Screen/correct actively — can independently worsen/mimic coma.

Diagnosis

P. falciparum parasitemia (thick smear=sensitivity, thin smear=species/quantification, or RDT) + unexplained coma. NUANCE: exclude other causes (bacterial meningitis, other CNS infection, metabolic) — incidental low-grade parasitemia in endemic patient ≠ automatically true cerebral malaria (common in holoendemic settings).

Treatment

IV ARTESUNATE = treatment of choice — superior mortality vs IV quinine in major trials, has SUPPLANTED quinine as 1st-line. Contrast vs uncomplicated malaria’s ORAL ACT (see Malaria topic) — severity + unreliable oral absorption in coma mandates parenteral route. Supportive: airway protection, seizure management, ACTIVE glucose monitoring/correction, careful fluid management (avoid both under-resuscitation AND fluid-overload/pulmonary complications — recognized concern in severe malaria). Substantial case fatality despite treatment → underscores prevention importance (vector control, chemoprophylaxis — Malaria topic).

The Single Species Responsible — A Genuinely Important Restriction

Cerebral malaria is, genuinely and specifically worth remembering as a high-yield restriction, caused essentially exclusively by Plasmodium falciparum (the general malaria biology, life cycle, and other species-specific patterns are covered under Malaria) — the other human-infecting Plasmodium species do not produce this severe CNS complication, meaning cerebral malaria functions, in effect, as a defining marker of severe, potentially life-threatening falciparum infection specifically, and its presence should immediately narrow diagnostic and epidemiological thinking toward this one species even before speciation is laboratory-confirmed.

Pathogenesis — Sequestration, Not Direct Neuroinvasion

The mechanism underlying cerebral malaria is genuinely, specifically distinctive and worth holding clearly in mind, since it differs fundamentally from every other CNS infection covered in this section: cerebral malaria does not involve the parasite directly invading neurons or CNS tissue the way a genuine CNS pathogen (bacteria, most CNS viruses) does. Instead, the defining process is microvascular sequestration — P. falciparum-infected red blood cells express a parasite-derived surface protein (PfEMP1) that mediates cytoadherence to vascular endothelium, causing infected erythrocytes to adhere to and accumulate within the cerebral microvasculature rather than circulating freely and being cleared by the spleen (the same general cytoadherence/immune-evasion mechanism that, more broadly, also drives other severe falciparum malaria complications, since this same sequestration process occurs in other vascular beds too, not the brain alone). This sequestration causes microvascular obstruction, localized hypoxia, and a substantial local inflammatory response, and this combination of mechanical obstruction and inflammation — not direct parasite presence within neural tissue — is what produces the resulting encephalopathy, a genuinely important, specifically testable pathogenic distinction from essentially every other topic in this CNS section.

Clinical Manifestations

Cerebral malaria is defined by unarousable coma in a patient with P. falciparum parasitaemia, with other CNS-attributable causes of coma excluded — genuinely important to remember as a diagnosis of exclusion within the appropriate epidemiological/parasitological context, rather than a syndrome with a single, unique confirmatory finding of its own. Seizures (particularly in children, in whom cerebral malaria is a leading cause of both severe childhood illness and death in endemic sub-Saharan African and, to a lesser but genuine extent, Indian settings) are common, and the disease carries a genuinely substantial mortality rate even with treatment, alongside a real risk of long-term neurological sequelae in survivors, particularly children (cognitive impairment, motor deficits, epilepsy) — a genuinely important point given how much of cerebral malaria’s disease burden extends beyond the acute mortality figure into lasting paediatric neurodevelopmental consequences. Hypoglycaemia is a genuinely important, specifically testable, frequently co-occurring complication in severe/cerebral malaria (from a combination of the parasite’s own glucose consumption, impaired hepatic gluconeogenesis, and, when used, quinine’s insulin-secretagogue effect), and should be actively screened for and corrected given hypoglycaemia’s own capacity to independently worsen or mimic altered consciousness.

Diagnosis

Diagnosis rests on demonstrating P. falciparum parasitaemia (by peripheral blood smear microscopy — thick smear for sensitivity, thin smear for species confirmation and parasitaemia quantification, as covered generally under Malaria — or by rapid diagnostic antigen test) in a patient presenting with unexplained coma, with other causes of altered consciousness in the relevant clinical/epidemiological context (bacterial meningitis, other CNS infections, metabolic causes) genuinely needing active consideration and, where feasible, exclusion — since coma with incidental, low-grade parasitaemia in an endemic-region patient does not necessarily equal true cerebral malaria, a real diagnostic nuance worth remembering given how common asymptomatic or low-grade parasitaemia can be in holoendemic settings.

Treatment

Intravenous artesunate is the treatment of choice for cerebral malaria and severe malaria more broadly (having demonstrated superior mortality outcomes compared with intravenous quinine in major clinical trials, and consequently having supplanted quinine as first-line therapy in current treatment guidelines) — genuinely important as a specifically testable point of contrast with uncomplicated malaria’s oral artemisinin-combination-therapy approach (see Malaria), since the severity and reduced/unreliable oral absorption reliability of a comatose patient specifically mandates the parenteral route. Supportive management is equally critical given the syndrome’s multi-system severity: airway protection and seizure management, active glucose monitoring and correction of hypoglycaemia (per the mechanism above), and careful fluid management (avoiding both under-resuscitation and the genuine risk of fluid-overload-related pulmonary complications, a real, specifically recognized concern in severe malaria management). Despite prompt, appropriate treatment, cerebral malaria genuinely carries a substantial case fatality rate, underscoring both the severity of this falciparum-specific complication and the corresponding importance of malaria prevention (vector control, chemoprophylaxis in appropriate travellers) covered under the general Malaria topic.

📝